Hot Pursuit     20-Apr-22
Alembic Pharma rises after receiving tentative approval for anti anginal drug
Alembic Pharmaceuticals gained 1.76% to Rs 761.95 after the drug maker received tentative approval from the US Food & Drug Administration (USFDA) for ivabradine tablets.
Ivabradine Tablets are indicated to reduce the risk of worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction. The tablets are also indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug, Corlanor Tablets of Amgen Inc. According to IQVIA, ivabradine tablets have an estimated market size of $102 million for twelve months ending December 2021.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

On a consolidated basis, the company reported a 39.7% fall in net profit to Rs 176.42 crore on a 3.2% fall in net sales to Rs 1,271.7 crore in Q3 FY22 over Q3 FY21.

Previous News
  Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
 ( Corporate News - 04-Jul-24   16:11 )
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 02-Jan-24   14:30 )
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Volumes soar at Lemon Tree Hotels Ltd counter
 ( Hot Pursuit - 02-Jan-24   11:00 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 20-Jul-23   14:30 )
  Alembic receives final approval for Fluorouracil Injection
 ( Corporate News - 06-Mar-23   11:32 )
  Volumes spurt at Blue Star Ltd counter
 ( Hot Pursuit - 20-Sep-23   14:30 )
Other Stories
  Reliance Industries Ltd up for third straight session
  08-Jul-24   13:06
  Oil & Natural Gas Corpn Ltd rises for third consecutive session
  08-Jul-24   13:05
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
  08-Jul-24   13:01
  Dr Reddys Laboratories Ltd gains for fifth session
  08-Jul-24   13:01
  HPL Electric soars after inking MoU with China-based Guangxi Ramway Tech
  08-Jul-24   12:40
  J&K Bank records 11% YoY growth in gross advances in Q1 FY25
  08-Jul-24   12:30
  Krebs Biochemicals & Industries Ltd leads gainers in 'B' group
  08-Jul-24   12:16
  Nykaa expects revenue growth around 22 to 23% YoY in Q1 FY25
  08-Jul-24   12:05
  Ajmera Realty spurts as sales value climbs 36% YoY in Q1
  08-Jul-24   12:02
  Kiri Industries Ltd leads gainers in 'A' group
  08-Jul-24   12:01
Back Top